|
|
Applicability of admixture of etomidate and propofol to painless gastroenteroscopy |
WANG Jinghua1, WANG Xuan2, WANG Xiaopeng3, ZHANG Xuhui1, FENG Zeguo4, ZHANG Xiaoying4, WANG Wei5, LIANG Xuemei6 |
1. Department of Anesthesiology, 3. Department of Gastroenterology, 6. Department of Medicial Administration, Hospital 305 of PLA, Beijing 100017,China; 2. Beijing Huilongguan Hospital, Beijing 100096,China; 4. Anesthesia and Operation Center, the First Medical Center, Chinese PLA General Hospital, Beijing 100853,China; 5. Department of Anesthesiology, Rocket Force Characteristic Medical Center of PLA, Beijing 100088,China |
|
|
Abstract Objective To investigate the applicability of intravenous administration of the admixture of etomidate and propofol to painless gastroenteroscopy.Methods Between February and May 2019, 240 patients undergoing painless gastroenteroscopy who met the requirements of anesthesia in our hospital were enrolled. These patients were randomly divided into two groups: propofol group (group P) and admixture of etomidate and propofol group (group E-P), with 120 patients in each. Anesthesia was induced by propofol in group P, but by the admixture of etomidate and propofol in group E-P. However, propofol alone was used in either group during maintenance of anesthesia. Non-invasive blood pressure (NBP), heart rate (HR) and saturation of pulse oximetry (SPO2) were monitored during anesthesia. All data was recorded, including the time of anesthesia induction, the time of gastroenteroscopy and awakening, as well as the number of such adverse reactions as circulatory inhibition, respiratory depression, injection pain and myoclonus in either group.Results There was significant difference in the incidence of circulatory inhibition, respiratory depression and injection pain (P=0.0184, P=0.0042, P<0.0001, respectively) between the two groups, which was significantly lower in group E-P(11.67% vs. 24.17%, 8.33% vs. 22.50%, 5.83% vs. 50.83%, respectively). The difference in the incidence of myoclonus was statistically significant (P<0.05), which was higher in group E-P(15.00% vs. 5.83%, P=0.0346).Conclusions The admixture of etomidate and propofol used for anesthesia induction in painless gastroenteroscopy can decrease the incidence of adverse reactions including injection pain and inhibition of circulation and respiration so that it can make painless gastroenteroscopy safer and more comfortable.
|
Received: 02 April 2020
|
|
|
|
|
[1] |
付 山,袁 磊,张宇峰,等. 丙泊酚和依托咪酯混合液持续泵注在无痛胃肠镜麻醉中的应用[J].现代生物医学进展,2016, 16(22): 4325-4328.
|
[2] |
冷 博,毛碧蓉,肖利威,等. 无痛胃镜在老年食管静脉曲张治疗中的疗效观察[J].医学综述,2014, 20(23): 4396-4398.
|
[3] |
夏江燕,陆新健,袁 静,等. 丙泊酚复合阿片类药物在胃镜检查中的应用[J].临床麻醉学杂志,2016, 32(5): 464-467.
|
[4] |
姜陆洋,武立民,施 英,等. 丙泊酚效应室靶控输注用于患心血管疾病老年人胃镜结肠镜联合检查的临床观察[J].中国实验诊断学,2014, 18(2): 252-255.
|
[5] |
吕永望. 依托咪酯与丙泊酚混合液在无痛人工流产中的应用效果观察[J].临床合理用药杂志,2018, 11(10): 91-92.
|
[6] |
Hadzija B W, Lubarsky D A. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia[J].Am J Health Syst Pharm, 1995, 52(9): 997-999.
|
[7] |
Saricaoglu F, Uzun S, Arun O, et al. A clinical comparison of etomidate-lipuro, propofol and admixture at induction[J].Saudi J Anaesth, 2011, 5(1): 62-66.
|
[8] |
马爱玲,张海峰,赵宁民,等. 丙泊酚注射液与依托咪酯脂肪乳注射液的配伍稳定性考察[J].中国医院药学杂志,2013, 33(21): 1822-1824.
|
[9] |
Wadhwa V, Issa D, Garg S, et al. Similar risk of cardiopulmonary adverse events between propofol and traditional anesthesia for gastrointestinal endoscopy: a systematic review and meta-analysis[J].Clin Gastroenterol Hepatol, 2017, 15(2): 194-206.
|
[10] |
Gilani M T, Bameshki A, Razavi M. Efficacy of ephedrine in the prevention of vascular pain associated with different infusion rates of propofol[J].Anesth Essays Res, 2014, 8(3): 345-348.
|
[11] |
Massad I M, Abu-Ali H M, Abu-Halaweh S A, et al. Venous occlusion with lidocaine for preventing propofol induced pain. A prospective double-blind randomized study[J].Saudi Med J, 2006, 27(7): 997-1000.
|
[12] |
Fahringer D L, Goodwin S R, Warde M K, et al. The effect of a 3 : 1 volume mixture of propofol 1% and thiopental 2.5% in reducing the pain on injection of propofol in children[J].Paediatr Anaesth, 2010, 20(6): 545-552.
|
[13] |
Pang W W, Huang P Y, Chang D P, et al. The peripheral analgesic effect of tramadol in reducing propofol injection pain: a comparison with lidocaine[J].Reg Anesth Pain Med, 1999, 24(3): 246-249.
|
[14] |
Sethi N, Jayaraman L, Sethi M, et al. Prevention of propofol pain: a comparative study[J]. Middle East J Anaesthesiol, 2009, 20(1): 71-74.
|
[15] |
Nishimoto R, Kashio M, Tominaga M. Propofol-induced pain sensation involves multiple mechanisms in sensory neurons[J].Pflugers Arch, 2015, 467(9): 2011-2020.
|
[16] |
Desousa K A. Pain on propofol injection: causes and remedies[J].Indian J Pharmacol, 2016, 48(6): 617-623.
|
[17] |
Wu G N, Xu H J, Liu F F, et al. Low-dose ketamine pretreatment reduces the incidence and severity of myoclonus induced by etomidate: a randomized, double-blinded, controlled clinical trial[J].Medicine (Baltimore), 2016, 95(6): e2701.
|
[18] |
Isitemiz I, Uzman S, Toptas M, et al. Prevention of etomidate-induced myoclonus: which is superior: fentanyl, midazolam, or a combination? A retrospective comparative study[J].Med Sci Monit, 2014, 20: 262-267.
|
[19] |
Reddy R V, Moorthy S S, Dierdorf S F, et al. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol[J].Anesth Analg, 1993, 77(5): 1008-1011.
|
[20] |
Preziosi P, Vacca M. Adrenocortical suppression and other endocrine effects of etomidate[J]. Life Sci, 1988, 42(5): 477-489.
|
[21] |
Yates A M, Wolfson A B, Shum L, et al. A descriptive study of myoclonus associated with etomidate procedural sedation in the ED[J].Am J Emerg Med, 2013, 31(5): 852-854.
|
[22] |
Zhou X, Li B X, Chen L M, et al. Etomidate plus propofol versus propofol alone for sedation during gastroscopy: a randomized prospective clinical trial[J].Surg Endosc, 2016, 30(11): 5108-5116.
|
|
|
|